Global · English Microbiome medicine · Clinical translation

Luc Rui · Microbiome medicine

From the gut
microbiome,
rethinking treatment.

Luc Rui is a clinical translation platform for microbiome medicine—standardising faecal microbiota transplantation (FMT), supporting research and building the next generation of microbial therapies.

Founded2012 · Shanghai
PlatformStandardised FMT
BaseBengbu · Anhui
A male physician in a white coat and stethoscope reviewing a tablet against a grey backdrop Clinical collaboration / 01
Starting from clinical questionsInvestigator-initiated microbiome research with hospital teams
FMT
Standardised

Who we are

We believe the microbiome is a vital dimension of human health. Luc Rui connects basic research, standardised preparation and clinical practice to move FMT from experience to reproducible standards.

Since 2012, we have built donor management, preparation quality control, cold-chain logistics and clinical collaboration around FMT—and brought real clinical questions back into research and industrialisation.

Discover Luc Rui
Founded / Shanghai
2012

A Shanghai-based company focused on translating microbiome medicine.

About us
Operating network
7companies

A network connecting clinical and industrial resources across China.

Our network
Bengbu industrial base
2,800m²

An FMT industrial base with a total investment of RMB 150 million.

The base
National R&D programme
47.9M

Total project funding of a national key R&D programme (RMB).

Research
Digital control centre at the Luc Rui industrial base
Bengbu · AnhuiMicrobiome and FMT industrial base / digital control centre

Infrastructure / Quality

A base built for standardisation.

In 2023, Luc Rui, the Bengbu government and Shanghai Tenth People's Hospital co-built an intestinal microbiome and FMT industrial base—bringing donor management, preparation, testing, cold chain and data traceability into one system.

01

2,800 m²

Industrial base covering preparation, testing and R&D.

02

RMB 150m

Total project investment, built with public partners.

03

1m vials / year

Designed annual capacity for clinical supply.

04

3m capsules / year

Designed annual capacity for oral formats.

Pipeline

From FMT,
to the next generation of microbiome therapies.

Standardised FMT is the starting point, not the destination. We are working across formats, strains and mechanisms to move complex microbial communities toward defined, verifiable products.

01

Standardised FMT

Donor screening, vial and capsule preparation, cold-chain delivery and traceability.

Established
02

Next-generation 2.0

Continuing optimisation of format, tolerability and clinical usability.

Iteration
03

Functional strains

Moving from complex communities to defined, standardisable strain combinations.

Research
04

Live biotherapeutics

Development under pharmaceutical standards, pending mechanism, process and clinical validation.

Long term

Clinical collaboration

The best evidence
comes from the clinic.

We work with clinical teams to frame questions, design studies and feed every learning back into the standardised system.

Start a collaboration
01

Gastrointestinal disease & FMT

Research on the standardised use and mechanisms of FMT in digestive disease.

02

Autism with co-occurring GI symptoms

Investigator-initiated research focused on GI symptoms, sleep and daily function.

03

Resistant bacteria & transplant complications

Working with critical care, haematology and transplant teams to explore clinical boundaries.

These are investigator-initiated research directions, not product indications or efficacy claims. FMT must be delivered by qualified healthcare institutions under appropriate indications and informed consent; findings require larger, controlled studies.

News & insights

Progress,
in plain sight.

Company updates, research collaboration and observations on a technology moving from the lab into clinical practice.

Contact

Start a conversation.

01 / Shanghai

Shanghai headquarters

China · Shanghai
Corporate, clinical and business teams

02 / Bengbu

Bengbu industrial base

Anhui · China
Microbiome and FMT industrial base

03 / Partnerships

Clinical, research & media

Use the form to reach the relevant team.

What are you looking for?

Tell us a little about your organisation and the conversation you would like to have. This is a design prototype—no data is sent or stored.

Prototype form. No backend connection or data storage.

Continue to exploreBack to who we are